Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, 401 N. Broadway, Suite 1440, Baltimore, MD, 21231, USA.
Radiation Medicine, Zucker School of Medicine At Hofstra/Northwell, Lake Success, USA.
Radiat Oncol. 2021 Mar 19;16(1):53. doi: 10.1186/s13014-021-01782-w.
Variation in target positioning represents a challenge to set-up reproducibility and reliability of dose delivery with stereotactic body radiation therapy (SBRT) for pancreatic adenocarcinoma (PDAC). While on-board imaging for fiducial matching allows for daily shifts to optimize target positioning, the magnitude of the shift as a result of inter- and intra-fraction variation may directly impact target coverage and dose to organs-at-risk. Herein, we characterize the variation patterns for PDAC patients treated at a high-volume institution with SBRT.
We reviewed 30 consecutive patients who received SBRT using active breathing coordination (ABC). Patients were aligned to bone and then subsequently shifted to fiducials. Inter-fraction and intra-fraction scans were reviewed to quantify the mean and maximum shift along each axis, and the shift magnitude. A linear regression model was conducted to investigate the relationship between the inter- and intra-fraction shifts.
The mean inter-fraction shift in the LR, AP, and SI axes was 3.1 ± 1.8 mm, 2.9 ± 1.7 mm, and 3.5 ± 2.2 mm, respectively, and the mean vector shift was 6.4 ± 2.3 mm. The mean intra-fraction shift in the LR, AP, and SI directions were 2.0 ± 0.9 mm, 2.0 ± 1.3 mm, and 2.3 ± 1.4 mm, respectively, and the mean vector shift was 4.3 ± 1.8 mm. A linear regression model showed a significant relationship between the inter- and intra-fraction shift in the AP and SI axis and the shift magnitude.
Clinically significant inter- and intra-fraction variation occurs during treatment of PDAC with SBRT even with a comprehensive motion management strategy that utilizes ABC. Future studies to investigate how these variations could lead to variation in the dose to the target and OAR should be investigated. Strategies to mitigate the dosimetric impact, including real time imaging and adaptive therapy, in select cases should be considered.
立体定向体部放射治疗(SBRT)治疗胰腺腺癌(PDAC)时,由于靶区定位的变化,难以实现剂量传递的可重复性和可靠性。虽然用于配准的机载成像可以进行每日调整以优化靶区定位,但由于分次内和分次间的变化,移位的幅度可能直接影响靶区覆盖和危及器官的剂量。本文旨在分析在大容量医疗中心接受 SBRT 治疗的 PDAC 患者的变化模式。
我们回顾了 30 例连续接受主动呼吸控制(ABC)SBRT 的患者。患者先与骨骼配准,然后再与基准点配准。回顾分次内和分次间的扫描,以量化各轴线上的平均和最大移位以及移位幅度。进行线性回归模型分析以研究分次间和分次内移位之间的关系。
LR、AP 和 SI 轴的平均分次间移位分别为 3.1±1.8mm、2.9±1.7mm 和 3.5±2.2mm,平均向量移位为 6.4±2.3mm。LR、AP 和 SI 方向的平均分次内移位分别为 2.0±0.9mm、2.0±1.3mm 和 2.3±1.4mm,平均向量移位为 4.3±1.8mm。线性回归模型显示 AP 和 SI 轴的分次间和分次内移位与移位幅度之间存在显著关系。
即使采用综合的运动管理策略,包括 ABC,在 SBRT 治疗 PDAC 时仍会发生明显的分次内和分次间变化。应研究这些变化如何导致靶区和 OAR 剂量变化的相关问题。在某些情况下,应考虑使用实时成像和自适应治疗等策略来减轻剂量学影响。